<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "22: principally attributable", fill: "#673147"},
{source: "22: principally attributable", target: "22: parent level corporate governance compliance", fill: "#673147"},
{source: "22: parent level corporate governance compliance", target: "22: local taxes", fill: "#673147"},
{source: "22: local taxes", target: "22: Medical Products ", fill: "#673147"},
{source: "22: Medical Products ", target: "22: increased salaries", fill: "#673147"},
{source: "22: increased salaries", target: "22: allowances", fill: "#673147"},
{source: "22: allowances", target: "22: lackluster sales", fill: "#673147"},
{source: "22: lackluster sales", target: "22: Healthcare Services ", fill: "#673147"},
{source: "22: Healthcare Services ", target: "22: hospital operations at", fill: "#673147"},
{source: "22: hospital operations at", target: "22: staff insurance costs supplies", fill: "#673147"},
{source: "22: principally attributable", target: "24: connection with maintenance", fill: "#e4d00a"},
{source: "24: connection with maintenance", target: "24: operation as well as", fill: "#e4d00a"},
{source: "24: operation as well as", target: "24: Healthcare Services ", fill: "#e4d00a"},
{source: "24: Healthcare Services ", target: "24: significant", fill: "#e4d00a"},
{source: "24: connection with maintenance", target: "25: Continued ", fill: "#bf00ff"},
{source: "25: Continued ", target: "25: divisions would reduce", fill: "#bf00ff"},
{source: "25: divisions would reduce", target: "25: available from operations", fill: "#bf00ff"},
{source: "25: available from operations", target: "25: operations", fill: "#bf00ff"},
{source: "25: operations", target: "25: indebtedness as well as limit", fill: "#bf00ff"},
{source: "25: Continued ", target: "45: Chinese ", fill: "#e9967a"},
{source: "45: Chinese ", target: "45: currency with", fill: "#e9967a"},
{source: "45: currency with", target: "45: foreign currency", fill: "#e9967a"},
{source: "45: Chinese ", target: "59: comply with", fill: "#0073cf"},
{source: "59: comply with", target: "59: regulations", fill: "#0073cf"},
{source: "59: regulations", target: "59: penalties loss", fill: "#0073cf"},
{source: "59: penalties loss", target: "59: licensure additional", fill: "#0073cf"},
{source: "59: licensure additional", target: "59: compliance costs", fill: "#0073cf"},
{source: "59: compliance costs", target: "59: adverse consequences", fill: "#0073cf"},
{source: "59: comply with", target: "60: Healthcare ", fill: "#536878"},
{source: "60: Healthcare ", target: "60: populous countries", fill: "#536878"},
{source: "60: populous countries", target: "60: comply with", fill: "#536878"},
{source: "60: comply with", target: "60: regulations at", fill: "#536878"},
{source: "60: regulations at", target: "60: government levels", fill: "#536878"},
{source: "60: Healthcare ", target: "121: medical capital equipment", fill: "#43b3ae"},
{source: "121: medical capital equipment", target: "121: certain extent upon", fill: "#43b3ae"},
{source: "121: certain extent upon", target: "121: availability", fill: "#43b3ae"},
{source: "121: availability", target: "121: budgeting processes", fill: "#43b3ae"},
{source: "121: budgeting processes", target: "121: Chinese Government ", fill: "#43b3ae"},
{source: "121: Chinese Government ", target: "121: Chinese ", fill: "#43b3ae"},
{source: "121: Chinese ", target: "121: banking system", fill: "#43b3ae"},
{source: "121: medical capital equipment", target: "128: financings from third party banks", fill: "#801818"},
{source: "128: financings from third party banks", target: "128: governments", fill: "#801818"},
{source: "128: governments", target: "128: every year", fill: "#801818"},
{source: "128: financings from third party banks", target: "141: In January ", fill: "#e48400"},
{source: "141: In January ", target: "141: implementing regulations", fill: "#e48400"},
{source: "141: implementing regulations", target: "141: such financings", fill: "#e48400"},
{source: "141: such financings", target: "141: government", fill: "#e48400"},
{source: "141: government", target: "141: finalizing", fill: "#e48400"},
{source: "141: finalizing", target: "141: US ExportImport Bank ", fill: "#e48400"},
{source: "141: US ExportImport Bank ", target: "141: commercial banks selected by", fill: "#e48400"},
{source: "141: In January ", target: "START_HERE", fill: "#e48400"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Health Care Supplies</td>
    </tr>
    <tr>
      <td>Health Care</td>
    </tr>
    <tr>
      <td>Health Care Equipment and Services</td>
    </tr>
    <tr>
      <td>Managed Health Care</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Human Resource and Employment Services</td>
    </tr>
    <tr>
      <td>Pharmaceuticals Biotechnology and Life Sciences</td>
    </tr>
    <tr>
      <td>Pharmaceuticals</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Independent Power Producers and Energy Traders</td>
    </tr>
    <tr>
      <td>Food Distributors</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>General Merchandise Stores</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Promise policy support</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Empathize</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Seize</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Comment</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Travel to meet</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Natural disaster</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Covert monitoring</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_figures">Significant figures</a></td>
      <td>Significant figures (also known as the significant digits, precision or resolution) of a number in positional notation are digits in the number that are reliable and necessary to indicate the quantity of something.\nIf a number expressing the result of a measurement (e.g., length, pressure, volume, or mass) has more digits than the number of digits allowed by the measurement resolution, then only as many digits as allowed by the measurement resolution are reliable, and so only these can be significant figures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bit_numbering">Bit numbering</a></td>
      <td>In computing, bit numbering is the convention used to identify the bit positions in a binary number.\n\n\n== Bit significance and indexing ==\n\nIn computing, the least significant bit (LSB) is the bit position in a binary integer representing the binary 1s place of the integer.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_form">Significant form</a></td>
      <td>Significant form refers to an aesthetic theory developed by English art critic Clive Bell which specified a set of criteria for what qualified as a work of art.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Others">Significant Others</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Statistical_significance">Statistical significance</a></td>
      <td>In statistical hypothesis testing, a result has statistical significance when it is very unlikely to have occurred given the null hypothesis. More precisely, a study's defined significance level, denoted by \n  \n    \n      \n        α\n      \n    \n    {\displaystyle \alpha }\n  , is the probability of the study rejecting the null hypothesis, given that the null hypothesis is true; and the p-value of a result, \n  \n    \n      \n        p\n      \n    \n    {\displaystyle p}\n  , is the probability of obtaining a result at least as extreme, given that the null hypothesis is true.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Simpsons">The Simpsons</a></td>
      <td>The Simpsons is an American animated sitcom created by Matt Groening for the Fox Broadcasting Company. The series is a satirical depiction of American life, epitomized by the Simpson family, which consists of Homer, Marge, Bart, Lisa, and Maggie.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Mother">Significant Mother</a></td>
      <td>Significant Mother is an American television sitcom created by Erin Cardillo and Richard Keith. Starring Josh Zuckerman, Nathaniel Buzolic and Krista Allen, it premiered on The CW network on August 3 and ended its run on October 5, 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Internet">Internet</a></td>
      <td>In finance and economics, interest is payment from a borrower or deposit-taking financial institution to a lender or depositor of an amount above repayment of the principal sum (that is, the amount borrowed), at a particular rate. It is distinct from a fee which the borrower may pay the lender or some third party.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation">Regulation</a></td>
      <td>Regulation is the management of complex systems according to a set of rules and trends. In systems theory, these types of rules exist in various fields of biology and society, but the term has slightly different meanings according to context.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulation_of_therapeutic_goods">Regulation of therapeutic goods</a></td>
      <td>The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Codes,_Rules_and_Regulations">New York Codes, Rules and Regulations</a></td>
      <td>The New York Codes, Rules and Regulations (NYCRR) contains New York state rules and regulations. The NYCRR is officially compiled by the New York State Department of State's Division of Administrative Rules.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Government_of_the_Republic_of_China">Government of the Republic of China</a></td>
      <td>The Government of the Republic of China, usually known as the Government of Taiwan, is the national government of the Republic of China (Taiwan), a unitary state in East Asia composed of Taiwan, Penghu, Kinmen, Matsu and other island groups in the "free area". The president is the head of state.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Nationalist_government">Nationalist government</a></td>
      <td>The Nationalist government, officially the National Government of the Republic of China (Chinese: 中華民國國民政府; pinyin: Zhōnghuámínguó Guómínzhèngfǔ; lit. 'Chinese People's State Nationals' Government'), also known as the Second Republic of China but most commonly known simply as the Republic of China, refers to the government of the Republic of China from 1 July 1925 to 20 May 1948, led by the Kuomintang (literally the "Nationals' Party").</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Chinese_government-in-exile">Chinese government-in-exile</a></td>
      <td>A government in exile (abbreviated as GiE) is a political group that claims to be a country or semi-sovereign state's legitimate government, but is unable to exercise legal power and instead resides in a foreign country. Governments in exile usually plan to one day return to their native country and regain formal power.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Annexation_of_Tibet_by_the_People's_Republic_of_China">Annexation of Tibet by the People's Republic of China</a></td>
      <td>Tibet came under the control of People's Republic of China (PRC) after the Government of Tibet accepted the Seventeen Point Agreement under Chinese pressure in October 1951.  This occurred after attempts by the Tibetan Government to gain international recognition, efforts to modernize its military, negotiations between the Government of Tibet and the PRC, and a military conflict in the Chamdo area of western Kham in October 1950.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Government_of_India">Government of India</a></td>
      <td>The Government of India (ISO: Bhārat Sarkār) (often abbreviated as GoI; also known as the Central or Union Government), or simply the Centre, is the federal governing authority of the Republic of India created by the Constitution of India as the legislative, executive and judicial authority to govern the union of twenty eight states and eight union territories. The president acts as the head of state and is the highest figure of authority, nominally, of the nation however it is the prime minister who is the chief executive.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Federal_government_of_the_United_States">Federal government of the United States</a></td>
      <td>The federal government of the United States (U.S. federal government or U.S. government) is the national government of the United States, a federal republic in North America, composed of 50 states, a city within a federal district (the city of Washington in the District of Columbia, where the entire federal government is based), five major self-governing territories and several island possessions. The federal government is composed of three distinct branches: legislative, executive, and judicial, whose powers are vested by the U.S. Constitution in the Congress, the president and the federal courts, respectively.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Borne_government">Borne government</a></td>
      <td>The Borne government is the forty-third and current government of the French Fifth Republic, formed on 16 May 2022 and headed by Élisabeth Borne as Prime Minister under the presidency of Emmanuel Macron.\n\n\n== Context ==\n\n\n=== Formation ===\nOn 16 May 2022, Jean Castex tendered the resignation of his government to the President of the Republic.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Military_government">Military government</a></td>
      <td>A military government is generally any government that is administered by military forces, whether or not this government is legal under the laws of the jurisdiction at issue, and whether this government is formed by natives or by an occupying power. It is usually carried out by military workers.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>CHINDEX INTERNATIONAL INC      ITEM 1A RISK FACTORS          You <font color="blue">should carefully</font> consider the risks described below, <font color="blue">together with</font>     all of the other information included in this <font color="blue">Annual Report </font>on Form 10-K     The  following  risks and <font color="blue">uncertainties</font> are not the only ones we face</td>
    </tr>
    <tr>
      <td>However, these are the risks our <font color="blue">management</font> believes are material</td>
    </tr>
    <tr>
      <td>If any of     the <font color="blue">following risks actually materialize</font>, our business, <font color="blue">financial condition</font>     or results of <font color="blue"><font color="blue">operations</font> could</font> be harmed</td>
    </tr>
    <tr>
      <td>This report <font color="blue">contains statements</font>     that are forward-looking</td>
    </tr>
    <tr>
      <td>These statements are <font color="blue">based on current expectations</font>     and <font color="blue">assumptions</font> that are subject to risks and <font color="blue">uncertainties</font> such as those     listed below and elsewhere in this report, which, among others, should be     considered in evaluating our <font color="blue">future performance</font>               <font color="blue">Risks Related </font>to Our Business and Financial Condition       Our business is <font color="blue">capital intensive</font> and we may not be able to access the     <font color="blue">capital markets</font> when we would like to <font color="blue">raise capital</font></td>
    </tr>
    <tr>
      <td>We may not be able to <font color="blue">raise adequate capital</font> to complete some or all of     our  business strategies or to <font color="blue">react rapidly</font> to changes in <font color="blue">technology</font>,     products, services or the <font color="blue"><font color="blue">competitive</font> landscape</font></td>
    </tr>
    <tr>
      <td><font color="blue">Healthcare </font>service and     <font color="blue">product providers</font> in China often face high <font color="blue">capital <font color="blue">requirements</font></font> in order to     take advantage of <font color="blue">new market <font color="blue">opportunities</font></font>, respond to <font color="blue">rigorous <font color="blue">competitive</font></font>     pressures  and  react  quickly  to  changes in <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Many of our     <font color="blue">competitors</font> are <font color="blue">committing</font> substantial capital and, in many instances, are     <font color="blue">forming alliances</font> to acquire or maintain <font color="blue">market <font color="blue">leadership</font></font></td>
    </tr>
    <tr>
      <td>There can be no     assurance that we will be able to satisfy our <font color="blue">capital <font color="blue">requirements</font></font> in the     future</td>
    </tr>
    <tr>
      <td>In particular, our strategy in the business of <font color="blue">providing healthcare</font>     services  includes  the  <font color="blue">establishment</font>  and  maintenance of healthcare     <font color="blue">facilities</font>, which require <font color="blue"><font color="blue">significant</font> capital</font></td>
    </tr>
    <tr>
      <td>In addition, we plan to     expand our <font color="blue"><font color="blue">distribution</font> <font color="blue">capabilities</font></font> for <font color="blue">medical products</font></td>
    </tr>
    <tr>
      <td>In the absence of     available capital, we would be unable to establish or maintain healthcare     <font color="blue">facilities</font>  as planned, and would be unable to expand our <font color="blue">distribution</font>     business as planned</td>
    </tr>
    <tr>
      <td>We do not presently have <font color="blue">sufficient capital resources</font>     to  implement  most  of our expansion plans in the absence of improved     financial performance, as to <font color="blue">which there</font> can be no assurance</td>
    </tr>
    <tr>
      <td>We may not <font color="blue">generate sufficient cash flow</font> to fund our <font color="blue">capital <font color="blue">expenditures</font></font>,     <font color="blue">ongoing <font color="blue">operations</font></font> and <font color="blue"><font color="blue">indebtedness</font> obligations</font></td>
    </tr>
    <tr>
      <td>Our ability to service our <font color="blue">indebtedness</font> and to fund planned capital     <font color="blue"><font color="blue">expenditures</font> will <font color="blue">depend on</font></font> our ability to <font color="blue">generate cash flow</font></td>
    </tr>
    <tr>
      <td>Our ability     to <font color="blue">generate cash flow</font> is <font color="blue">dependent on</font> many factors, including:                                        -6-       _________________________________________________________________             •   our future operating performance;         •   the demand for our services and products;         •   <font color="blue">general economic <font color="blue">conditions</font></font> and <font color="blue"><font color="blue">conditions</font> affecting suppliers</font>,     customers and patients;         •   <font color="blue">competition</font>; and         •   legal and <font color="blue"><font color="blue">regulatory</font> factors affecting us</font> and our business</td>
    </tr>
    <tr>
      <td>If we are unable to     <font color="blue">generate sufficient cash flow</font>, we may not be able to repay <font color="blue">indebtedness</font>,     operate our business, respond to <font color="blue">competition</font>, pursue our <font color="blue">growth strategy</font>,     which is <font color="blue">capital intensive</font>, or <font color="blue">otherwise meet cash <font color="blue">requirements</font></font></td>
    </tr>
    <tr>
      <td>We experienced a net loss in each of fiscal 2004, fiscal 2005 and fiscal     2006 and <font color="blue">may continue</font> to experience net losses</td>
    </tr>
    <tr>
      <td>Consequently, we may not     have the ability to <font color="blue">finance future <font color="blue">operations</font></font></td>
    </tr>
    <tr>
      <td>These net losses are <font color="blue">principally attributable</font> to increased     costs, including: at our parent level, corporate governance compliance and     <font color="blue">local taxes</font>; in our <font color="blue">Medical Products </font>division, <font color="blue">increased salaries</font>, bad debt     <font color="blue">allowances</font> and periods of <font color="blue">lackluster sales</font>; and, in our <font color="blue">Healthcare </font>Services     division,  in  fiscal  2004  and  fiscal  2005  periods,  start-up and     service-expansion expenses relating to <font color="blue">hospital <font color="blue">operations</font> at</font> SHU, including     increases in staff, insurance costs, supplies and other expenses</td>
    </tr>
    <tr>
      <td>In fiscal     2006 many of these <font color="blue">expenses diminished as <font color="blue">operations</font></font> in Shanghai commenced</td>
    </tr>
    <tr>
      <td>However, expenses in <font color="blue">connection with maintenance</font> and operation, as well as     expansion,  if  any,  of  our <font color="blue">Healthcare </font>Services division will remain     <font color="blue">significant</font></td>
    </tr>
    <tr>
      <td><font color="blue">Continued </font>losses in operating <font color="blue">divisions would reduce</font> the cash     <font color="blue">available from <font color="blue">operations</font></font> to service our <font color="blue">indebtedness</font>, as well as limit our     ability to finance our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If we fail to manage our growth or maintain <font color="blue">adequate internal accounting</font>,     <font color="blue">disclosure</font> and other controls, we would lose the ability to manage our     business  <font color="blue"><font color="blue">effective</font>ly</font>  and/or  experience errors or information lapses     <font color="blue">affecting public</font> reporting</td>
    </tr>
    <tr>
      <td>We have expanded our <font color="blue">operations</font> rapidly in <font color="blue">recent years</font> and continue to     <font color="blue">explore ways</font> to extend our product and <font color="blue">service offerings</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">growth may</font>     place a strain on our <font color="blue">management</font> systems, information systems, resources and     <font color="blue">internal controls</font></td>
    </tr>
    <tr>
      <td>Our ability to <font color="blue"><font color="blue">successfully</font> distribute products</font> and offer     services requires adequate information systems and resources and oversight     from senior <font color="blue">management</font></td>
    </tr>
    <tr>
      <td>We will need to modify and improve our financial and     <font color="blue">managerial controls</font>, reporting systems and procedures and other internal     control and <font color="blue">compliance procedures as</font> we continue to grow and expand our     business</td>
    </tr>
    <tr>
      <td>If we are unable to manage our growth and improve our controls,     systems and procedures, they may be <font color="blue">in<font color="blue">effective</font></font>, we may be unable to operate     <font color="blue">efficiently</font> and we may lose the ability to manage many other aspects of our     business  <font color="blue"><font color="blue">effective</font>ly</font>  and/or  experience errors or information lapses     <font color="blue">affecting public</font> reporting</td>
    </tr>
    <tr>
      <td>A <font color="blue">control system</font>, no matter <font color="blue">how well designed</font> and operated, cannot     <font color="blue">provide absolute assurance</font> that the <font color="blue">objectives</font> of the <font color="blue">control system</font> are     met, and <font color="blue">no evaluation</font> of controls can <font color="blue">provide absolute assurance</font> that all     <font color="blue">control issues</font> have been detected</td>
    </tr>
    <tr>
      <td>If we are not successful in <font color="blue">discovering</font>     and <font color="blue">eliminating weaknesses</font> in <font color="blue">internal controls</font>, then we will lose the     ability to manage our business <font color="blue"><font color="blue">effective</font>ly</font></td>
    </tr>
    <tr>
      <td>-7-       _________________________________________________________________           If  we  lost  the  services of our key personnel, then our <font color="blue">leadership</font>,     expertise, experience, business <font color="blue">relationships</font>, strategic and operational     planning and other important business <font color="blue">attributes would</font> be diminished</td>
    </tr>
    <tr>
      <td>Our success to a large <font color="blue">extent depends upon</font> the <font color="blue">continued services</font> of     certain executive officers, <font color="blue">particularly</font> Roberta Lipson, the Chief Executive     Officer and President, Lawrence Pemble, the Treasurer and Executive Vice     President  and Elyse Beth Silverberg, the Executive Vice President and     Secretary</td>
    </tr>
    <tr>
      <td>We have <font color="blue">entered into</font> an <font color="blue"><font color="blue">employment</font> <font color="blue">agreement</font> with</font> Ms</td>
    </tr>
    <tr>
      <td>Lipson that     contains non-<font color="blue">competition</font>, non-solicitation and <font color="blue">confidentiality provisions</font>,     and  we  maintain  key-person life insurance coverage in the amount of     dlra2cmam000cmam000 on the life of Ms</td>
    </tr>
    <tr>
      <td>Pemble is subject to an <font color="blue">employment</font>     <font color="blue">agreement</font>   that   contains   non-<font color="blue">competition</font>,   non-solicitation  and     <font color="blue">confidentiality provisions</font>, but we do not maintain an <font color="blue">insurance policy on</font>     his life</td>
    </tr>
    <tr>
      <td><font color="blue">Silverberg </font>is subject to an <font color="blue">employment</font> <font color="blue">agreement</font> that contains     non-<font color="blue">competition</font>, non-solicitation and <font color="blue">confidentiality provisions</font>, but we do     not maintain an <font color="blue">insurance policy on</font> her life</td>
    </tr>
    <tr>
      <td>The loss of service of any of     our <font color="blue">key employees could diminish</font> our <font color="blue">leadership</font>, expertise, experience,     business <font color="blue">relationships</font>, strategic and operating planning and other important     business attributes, thus materially harming our business</td>
    </tr>
    <tr>
      <td>Our business could be <font color="blue"><font color="blue">adversely</font> affected by inflation</font> or <font color="blue">foreign currency</font>     <font color="blue">fluctuation</font></td>
    </tr>
    <tr>
      <td>Since  we  receive more than 70prca of our revenues in local <font color="blue">Chinese     </font>currency, with the remainder in US dollars (USD), we have <font color="blue">foreign currency</font>     risk</td>
    </tr>
    <tr>
      <td><font color="blue">Contracts </font><font color="blue">denominated</font> in USD, where the goods are purchased in USD,     would not be subject to <font color="blue">foreign currency</font> risk</td>
    </tr>
    <tr>
      <td>In the event of a decline in     the value of the USD, however, goods that are <font color="blue">purchased by us</font> in USD and     resold  in Chinese Renminbi (RMB) would become more <font color="blue">competitive</font> in the     Chinese market, which would allow us to <font color="blue">either reduce prices</font> and increase     quantities or maintain prices at a higher gross <font color="blue">profit margin</font></td>
    </tr>
    <tr>
      <td>Similarly,     changes in the valuation of the <font color="blue">RMB or Hong Kong Dollar </font>may have an impact     on  our results of <font color="blue">operations</font> in the future</td>
    </tr>
    <tr>
      <td>Our <font color="blue">subsidiaries</font>, Chindex     Tianjin, Chindex Shanghai, BJU, and SHU, <font color="blue">sell products</font> and services in RMB     We  have <font color="blue">also purchased</font> and will continue to purchase some products in     Western currencies other than USD and have sold and will continue to sell     such products <font color="blue">in China for USD To </font>the extent that the value <font color="blue">of the USD     </font><font color="blue">declines against such</font> Western currencies, we could experience a negative     <font color="blue"><font color="blue">impact on</font> profitability</font></td>
    </tr>
    <tr>
      <td>As part of our risk <font color="blue">management</font> program, we also perform <font color="blue">sensitivity</font>     analyses to <font color="blue">assess potential</font> changes in revenue, operating results, cash     flows and <font color="blue">financial position</font> relating to <font color="blue">hypothetical movements</font> in currency     <font color="blue">exchange rates</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">sensitivity</font> analysis of changes in the <font color="blue">fair value</font> of the     RMB  to the USD at March 31, 2006, indicated that if the USD uniformly     increased in value by 10prca relative to the RMB, then we would experience a 9prca     <font color="blue">smaller loss</font></td>
    </tr>
    <tr>
      <td>Conversely, a 10prca increase in the value of the RMB relative to     the USD at March 31, 2006 would have resulted in a 10prca <font color="blue">additional</font> loss</td>
    </tr>
    <tr>
      <td>Risks Relating to the <font color="blue">Healthcare </font>Services Division       If we do not attract and retain qualified physicians, administrators or     other  hospital  personnel, our hospital <font color="blue">operations</font> would be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>Our success in operating our hospitals and <font color="blue">clinics will</font> be, in part,     <font color="blue">dependent upon</font> the number and quality of physicians on the <font color="blue">medical staffs</font> of     these  hospitals  and  our ability to maintain good <font color="blue">relations with</font> our     physicians</td>
    </tr>
    <tr>
      <td>As we offer international standard <font color="blue">healthcare at</font> our hospitals     and clinics, we are further <font color="blue">dependent on</font> attracting a limited number of     qualified Western <font color="blue">medical professionals</font>, not all of whom have long-term     <font color="blue"><font color="blue">relationships</font> with</font> China</td>
    </tr>
    <tr>
      <td><font color="blue">Physicians </font><font color="blue">may terminate</font> their <font color="blue">affiliation with</font>     our <font color="blue">hospitals at</font> any time</td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">successfully</font> maintain good     <font color="blue"><font color="blue">relationships</font> with</font> physicians, our results of <font color="blue">operations</font> may be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>In  addition,  the  failure to recruit and retain qualified     <font color="blue">management</font>, nurses and other <font color="blue">medical support personnel</font>, or to <font color="blue">control labor</font>     costs,  could  have  an  adverse effect on our business and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>-8-       _________________________________________________________________           Our  business  is  heavily  regulated and failure to <font color="blue">comply with</font> those     <font color="blue">regulations</font>  could  result in penalties, loss of licensure, <font color="blue">additional</font>     <font color="blue">compliance costs</font> or other <font color="blue">adverse <font color="blue">consequences</font></font></td>
    </tr>
    <tr>
      <td><font color="blue">Healthcare </font>providers in China, as in most other <font color="blue">populous countries</font>, are     required to <font color="blue">comply with</font> many laws and <font color="blue">regulations</font> at the national and local     <font color="blue"><font color="blue">government</font> levels</font></td>
    </tr>
    <tr>
      <td>These laws and <font color="blue">regulations</font> relate to: licensing; the     conduct  of  <font color="blue">operations</font>;  the  <font color="blue"><font color="blue">relationships</font> among hospitals</font> and their     <font color="blue">affiliated</font>  providers;  the  ownership  of <font color="blue">facilities</font>; the addition of     <font color="blue">facilities</font> and services; confidentiality, maintenance and <font color="blue">security issues</font>     associated  with medical records; billing for services; and prices for     services</td>
    </tr>
    <tr>
      <td>If we fail to <font color="blue">comply with</font> applicable laws and <font color="blue">regulations</font>, we     <font color="blue">could suffer penalties</font>, including the loss of our licenses to operate</td>
    </tr>
    <tr>
      <td>In     addition,  further  <font color="blue">healthcare legislative reform</font> is likely, and could     materially <font color="blue">adversely</font> affect our business and results of <font color="blue">operations</font> in the     event we do not comply or if the cost of compliance is expensive</td>
    </tr>
    <tr>
      <td>The above     list of <font color="blue">certain regulated areas</font> is not <font color="blue">exhaustive</font> and it is not possible to     anticipate the exact nature of future <font color="blue">healthcare legislative reform</font> in     China</td>
    </tr>
    <tr>
      <td><font color="blue">Depending </font>on the priorities determined by the <font color="blue">Chinese Ministry </font>of     Health, the political climate at any given time, the continued <font color="blue">development</font>     <font color="blue">of <font color="blue">the Chinese </font></font><font color="blue">healthcare system</font> and many other factors, future legislative     reforms  may  be <font color="blue">highly diverse</font>, including <font color="blue">stringent infection control</font>     policies, improved rural healthcare <font color="blue">facilities</font>, increased regulation of the     <font color="blue">distribution</font>  of  <font color="blue">pharmaceuticals</font>  and  numerous other <font color="blue">policy matters</font></td>
    </tr>
    <tr>
      <td>Consequently, the <font color="blue">implications</font> of these future reforms could result in     penalties, loss of licensure, <font color="blue">additional</font> <font color="blue">compliance costs</font> or other adverse     <font color="blue">consequences</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">operations</font> could</font> be <font color="blue">adversely</font> affected by the high cost of malpractice     insurance</td>
    </tr>
    <tr>
      <td>In <font color="blue">recent years</font>, physicians, hospitals and other <font color="blue">healthcare providers</font>     in the US have become subject to an increasing number of <font color="blue">legal actions</font>     alleging  malpractice or related <font color="blue">legal theories</font></td>
    </tr>
    <tr>
      <td>Many of these actions     involve large claims and <font color="blue">significant</font> legal costs</td>
    </tr>
    <tr>
      <td>While similar lawsuits are     not common in China, to protect us from the cost of any such claims, we     generally maintain <font color="blue">professional malpractice <font color="blue">liability</font> insurance</font> and general     <font color="blue"><font color="blue">liability</font> insurance coverage</font> in amounts and <font color="blue">with deductibles</font> that we believe     to be <font color="blue">appropriate</font> for our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>However, our insurance coverage may     not cover all claims <font color="blue">against us</font> or continue to be <font color="blue">available at</font> a reasonable     cost for us to maintain <font color="blue">adequate levels</font> of insurance</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> information systems, which if not implemented and maintained     could <font color="blue">adversely</font> affect our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">healthcare services</font> business is <font color="blue">dependent on</font> <font color="blue">effective</font> information     systems that <font color="blue">assist us</font> in, among other things, monitoring utilization and     other  cost  factors, supporting our healthcare <font color="blue">management</font> techniques,     <font color="blue">processing billing</font> and <font color="blue">providing data</font> to <font color="blue">regulators</font></td>
    </tr>
    <tr>
      <td>If we experience a     reduction in the performance, re<font color="blue">liability</font> or <font color="blue">availability</font> of our information     systems, our <font color="blue">operations</font> and ability to produce timely and accurate reports     could be <font color="blue">adversely</font> impacted</td>
    </tr>
    <tr>
      <td>Our information systems and <font color="blue">applications</font> require <font color="blue">continual maintenance</font>,     upgrading and <font color="blue">enhancement</font> to <font color="blue">meet operational</font> needs</td>
    </tr>
    <tr>
      <td>Moreover, the proposed     expansion of <font color="blue">facilities</font> and similar <font color="blue">activities</font> require <font color="blue">transitions</font> to or     from, and the <font color="blue">integration</font> of, various information systems</td>
    </tr>
    <tr>
      <td>We regularly     upgrade and expand our information <font color="blue">systems <font color="blue">capabilities</font></font> and implemented in     fiscal 2006 new clinical and financial reporting <font color="blue">systems throughout</font> our     <font color="blue">healthcare services</font> <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>This implementation, future upgrades to it     and other proposed system-wide improvements in information systems are     expected to require <font color="blue">capital <font color="blue">expenditures</font></font></td>
    </tr>
    <tr>
      <td>If we experience <font color="blue"><font color="blue">difficulties</font> with</font>     the transition to or from information systems or are unable to properly     implement, finance, maintain or expand our systems, we could suffer, among     other things, from operational disruptions, which could <font color="blue">adversely</font> affect our     prospects or results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>-9-       _________________________________________________________________           Our <font color="blue">operations</font> face <font color="blue">competition</font> that could <font color="blue">adversely</font> affect our results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Our Beijing and Shanghai </font>healthcare <font color="blue">facilities</font> <font color="blue">compete with</font> a large     number and variety of healthcare <font color="blue">facilities</font> in their <font color="blue">respective markets</font></td>
    </tr>
    <tr>
      <td>There are numerous Chinese <font color="blue">hospitals available</font> to the general populace, as     <font color="blue">well as international clinics serving</font> the expatriate business and diplomatic     <font color="blue">community</font></td>
    </tr>
    <tr>
      <td>Although we believe that <font color="blue">existing international clinics</font> do not     currently provide <font color="blue">competitive</font>, specialized international standard services     in  <font color="blue">Beijing or Shanghai</font>, there can be no assurance that these or other     clinics, hospitals or other <font color="blue">facilities</font> will not commence or <font color="blue">expand such</font>     <font color="blue">operations</font>, which would increase their <font color="blue">competitive</font> edge</td>
    </tr>
    <tr>
      <td>Further, there can     be no assurance that a qualified Western or other healthcare organization,     having  <font color="blue">greater resources</font> in the provision or <font color="blue">management</font> of healthcare     services, will not decide to engage in <font color="blue">operations</font> similar to those being     <font color="blue">conducted by us</font> in <font color="blue">Beijing or Shanghai</font></td>
    </tr>
    <tr>
      <td><font color="blue">Expansion </font>of <font color="blue">healthcare services</font> to reach <font color="blue">the Chinese </font><font color="blue">population depends</font> to     some extent on the <font color="blue">development</font> of an <font color="blue">insurance product which</font> is not now     available</td>
    </tr>
    <tr>
      <td>Medical insurance is not <font color="blue">generally available</font> to <font color="blue">the Chinese </font>population     and so visits to our hospital <font color="blue">facilities</font> by the <font color="blue">local population</font> are usually     paid for in cash</td>
    </tr>
    <tr>
      <td>Our expansion plans call for increasing the number of     local  Chinese who use our <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>In order to achieve this we are     working <font color="blue">with various <font color="blue">organizations</font></font> to develop an <font color="blue">insurance product which</font>     <font color="blue">would cover</font> some or all of the costs of visits to our <font color="blue">facilities</font> and thus     <font color="blue"><font color="blue">effective</font>ly</font> open up the <font color="blue">market on</font> a <font color="blue">broader basis</font></td>
    </tr>
    <tr>
      <td>If <font color="blue">such efforts fail</font> our     ability to continue to grow the <font color="blue">Healthcare </font>Services division of the <font color="blue">Company     </font>could be at risk</td>
    </tr>
    <tr>
      <td>Our  loan  from  the  International  Finance  Corporation (IFC) places     <font color="blue">restrictions on</font> the conduct of our <font color="blue">healthcare services</font> business</td>
    </tr>
    <tr>
      <td>The loan from the International Finance Corporation (IFC) to BJU and     SHU, which is <font color="blue">guaranteed by</font> the <font color="blue">parent corporation</font>, requires us to achieve     specified  liquidity  and  coverage  ratios  and  meet other operating     <font color="blue">requirements</font>  in  order  for us to <font color="blue">conduct certain <font color="blue">transactions</font></font> in our     <font color="blue">healthcare services</font> business</td>
    </tr>
    <tr>
      <td>The  terms  of  our  <font color="blue">indebtedness</font> with the IFC impose <font color="blue">significant</font>     <font color="blue">restrictions on</font> our business</td>
    </tr>
    <tr>
      <td>The <font color="blue">indentures governing</font> our outstanding notes     and the <font color="blue">agreement</font> governing our <font color="blue">loan contain various covenants</font> that limit     the ability of our hospitals to, among other things: (1) incur or guarantee     <font color="blue">additional</font>  <font color="blue">indebtedness</font>, (2) create or permit to exist <font color="blue">certain liens</font>,     (3) enter  into  business <font color="blue">combinations</font> and <font color="blue">asset sale <font color="blue">transactions</font></font></td>
    </tr>
    <tr>
      <td>In     addition, the loan <font color="blue">agreement</font> also creates liquidity and <font color="blue">coverage ratios</font> and     other operating <font color="blue">requirements</font> that limit the ability of our hospitals to,     among other things: (1) make <font color="blue">intercompany payments</font>, including dividends and     <font color="blue">management</font> fees to affiliate companies, (2) make <font color="blue">investment</font>s, <font color="blue">enter into</font>     <font color="blue">transactions</font>  with  <font color="blue">affiliates</font>,  (3) incur  <font color="blue">expenditures</font>  for fixed or     non-current assets</td>
    </tr>
    <tr>
      <td>These <font color="blue">restrictions could limit</font> our ability to obtain future financing,     make  <font color="blue">acquisitions</font>  or needed <font color="blue">capital <font color="blue">expenditures</font></font>, withstand a future     downturn in our business, conduct <font color="blue">operations</font> or otherwise take advantage of     business <font color="blue">opportunities</font> that may arise</td>
    </tr>
    <tr>
      <td>Our loan <font color="blue">agreement</font> also requires us     to maintain <font color="blue">specified financial ratios</font> and our ability to do so may be     <font color="blue">affected by events beyond</font> our <font color="blue">control such as</font> business <font color="blue">conditions</font> in China</td>
    </tr>
    <tr>
      <td>Our  failure  to  maintain  applicable  financial  ratios,  in certain     <font color="blue">circumstances</font>, would limit or <font color="blue">prevent us from</font> making <font color="blue">payments from</font> the     hospitals to the <font color="blue">parent company</font> and <font color="blue">would otherwise limit</font> the hospitals’     <font color="blue">flexibility</font> in <font color="blue">financial matters</font></td>
    </tr>
    <tr>
      <td>Risks relating to our <font color="blue">Medical Products </font>division       We <font color="blue">depend on</font> our <font color="blue">relations with</font> suppliers and would be <font color="blue">adversely</font> affected by     the <font color="blue">termination</font> of <font color="blue"><font color="blue">arrangements</font> with</font>, or shortage or loss of any <font color="blue">significant</font>     <font color="blue">product line from them</font></td>
    </tr>
    <tr>
      <td>We rely on a limited number of suppliers that account for a <font color="blue">significant</font>     portion  of our revenues</td>
    </tr>
    <tr>
      <td>During the <font color="blue">fiscal year</font> ended March 31, 2006,     Siemens  Medical Solutions (Siemens) and Guidant Corporation (Guidant)     represented 49prca and 22prca of our <font color="blue">product revenue</font> and were the <font color="blue">only suppliers</font>     where  such  percentage was at least 10prca</td>
    </tr>
    <tr>
      <td>During the <font color="blue">fiscal year</font> ended     March 31, 2005, Siemens and                                        -10-       _________________________________________________________________           Guidant represented 39prca and 18prca of our <font color="blue">product revenue</font> and were the only     suppliers where <font color="blue">such percentage</font> was at least 10prca</td>
    </tr>
    <tr>
      <td>During the <font color="blue">fiscal year</font>     ended March 31, 2004, Siemens, Guidant and Becton-Dickenson (BD) represented     17prca, 14prca and 10prca of our <font color="blue">product revenue</font> and were the <font color="blue">only suppliers</font> where     <font color="blue">such percentage</font> was at least 10prca</td>
    </tr>
    <tr>
      <td>Although a substantial number of our     <font color="blue"><font color="blue">relationships</font> with</font> our capital equipment suppliers are pursuant to exclusive     contracts, including Siemens (but not the other <font color="blue">suppliers named</font> above), with     which  we  have  a 5-year contract terminable for failure to meet sale     <font color="blue">objectives</font>, the <font color="blue">relationships</font> are <font color="blue">based <font color="blue">substantially</font> on mutual satisfaction</font>     in addition to the terms of the <font color="blue">contractual <font color="blue">arrangements</font></font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">agreement</font> with     Siemens <font color="blue">expires on</font> <font color="blue">September </font>25, 2006 and there is no assurance that the     <font color="blue">agreement</font> will be extended in whole or in part</td>
    </tr>
    <tr>
      <td>If the <font color="blue">agreement</font> is not     extended this could have a <font color="blue">significant</font> effect on our revenue</td>
    </tr>
    <tr>
      <td>Our <font color="blue">agreement</font>     with Guidant <font color="blue">expired on</font> <font color="blue">December </font>31, 2005, but the business has <font color="blue">continued on</font>     the <font color="blue">same terms at will</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">agreement</font> with BD, which we <font color="blue">no longer represent</font>,     <font color="blue">expired by</font> its terms on <font color="blue">December </font>31, 2004</td>
    </tr>
    <tr>
      <td>None of these <font color="blue">agreement</font>s contains     short-term <font color="blue">cancellation</font> provisions, except typical provisions allowing     <font color="blue">cancellation</font> for breach of contract, <font color="blue">bankruptcy</font>, change of ownership, etc     <font color="blue">Certain  </font>of  our contracts with our other suppliers contain short-term     <font color="blue">cancellation</font> provisions permitting the contracts to be terminated on short     notice (from 30 days to six months), minimum sales quantity <font color="blue">requirements</font> or     targets and provisions triggering <font color="blue">termination</font> upon the occurrence of certain     events</td>
    </tr>
    <tr>
      <td>From time to time, we and/or our <font color="blue">suppliers terminate</font> or revise our     respective  <font color="blue">distribution</font>  <font color="blue">arrangements</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that     <font color="blue">cancellation</font>s of, or other material <font color="blue">adverse effects on</font> our contracts, will     not occur</td>
    </tr>
    <tr>
      <td>As an example of the foregoing risk, as previously disclosed, BD     established a subsidiary in China that performs <font color="blue">certain services previously</font>     performed by us</td>
    </tr>
    <tr>
      <td>In that example, we did not have a <font color="blue">binding contractual</font>     <font color="blue">arrangement limiting</font> BD’s decision to <font color="blue">internalize <font color="blue">rather than</font> outsource</font>     those services to us</td>
    </tr>
    <tr>
      <td>There can be no assurance that our <font color="blue">suppliers will</font> not     elect to change their method of <font color="blue">distribution</font> into <font color="blue">the Chinese </font>marketplace to     a form that does not use our services</td>
    </tr>
    <tr>
      <td>Our  sales  of <font color="blue">medical products</font> depend to some extent on our suppliers     continuing to improve their products and <font color="blue">introduce new models</font></td>
    </tr>
    <tr>
      <td>If a supplier     fails to upgrade its product line as quickly as <font color="blue">competitive</font> <font color="blue"><font color="blue">manufacture</font>rs</font>     have done this could <font color="blue">adversely</font> impact our revenues</td>
    </tr>
    <tr>
      <td>The market for <font color="blue">medical equipment</font> in China is highly <font color="blue">competitive</font> and     buyers are very interested in purchasing the latest <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>In operating     under exclusive <font color="blue">agreement</font>s with certain <font color="blue"><font color="blue">manufacture</font>rs</font> we are tied to a     <font color="blue">single source</font> in <font color="blue">each product area</font> and are <font color="blue">dependent on</font> the <font color="blue">acceptance</font> of     the <font color="blue"><font color="blue">manufacture</font>rs</font>’ products in the market place</td>
    </tr>
    <tr>
      <td>If there is a delay in the     <font color="blue">introduction</font> of <font color="blue">new products</font> or <font color="blue">technology</font> this <font color="blue">could influence buyers</font> to     choose <font color="blue">competitive</font> offerings from other companies</td>
    </tr>
    <tr>
      <td>Timing  of  revenues  and  <font color="blue">fluctuation</font>s  in financial performance vary     <font color="blue">significant</font>ly from quarter to quarter and are not <font color="blue">necessarily</font> <font color="blue">indicative</font> of     our performance over longer periods</td>
    </tr>
    <tr>
      <td>The timing of our revenues is affected by several <font color="blue">significant</font> factors</td>
    </tr>
    <tr>
      <td>Many end-users of the <font color="blue">medical capital equipment</font> that we sell depend to a     <font color="blue">certain extent upon</font> the <font color="blue">availability</font> of funds in the <font color="blue">budgeting processes</font> of     the <font color="blue">Chinese Government </font>and the <font color="blue">availability</font> of credit from the <font color="blue">Chinese     </font><font color="blue">banking system</font> and otherwise</td>
    </tr>
    <tr>
      <td>These processes and the <font color="blue">availability</font> of credit     fluctuate  in  amounts  and  timing  because  they are <font color="blue">based on policy</font>     de<font color="blue">termination</font>s by the <font color="blue">Chinese Government </font>and the <font color="blue">discretion</font> of financial     <font color="blue">institutions</font></td>
    </tr>
    <tr>
      <td>Further, in light of the <font color="blue">dependence by purchasers on</font> the     <font color="blue">availability</font> of credit, the timing of <font color="blue">sales may depend upon</font> the timing of     our or our purchasers’ abilities to arrange for credit sources</td>
    </tr>
    <tr>
      <td>A <font color="blue">relatively</font>     limited number of orders and shipments of <font color="blue">medical capital equipment</font> may     <font color="blue">constitute</font>  a <font color="blue">meaningful percentage</font> of our revenues in any one period</td>
    </tr>
    <tr>
      <td>Correspondingly, a <font color="blue">relatively</font> small reduction in the number of orders can     have  a material <font color="blue">impact on</font> our revenues in any <font color="blue">one quarter</font> or year</td>
    </tr>
    <tr>
      <td>In     addition, because we recognize revenues and expenses relating to certain     <font color="blue">contracts as products</font> are shipped, the timing of <font color="blue">shipments affects</font> our     operating  results for a <font color="blue">particular period</font></td>
    </tr>
    <tr>
      <td>As a result, our operating     results have varied and are expected to continue to vary <font color="blue">significant</font>ly from     quarter to quarter and our results of <font color="blue">operations</font> for any <font color="blue">particular quarter</font>     are not <font color="blue">necessarily</font> <font color="blue">indicative</font> of results that may be expected for any     <font color="blue">subsequent quarter</font> or related <font color="blue">fiscal year</font></td>
    </tr>
    <tr>
      <td>-11-       _________________________________________________________________           We have not been able to arrange <font color="blue">financings</font>, from third party banks or     <font color="blue"><font color="blue">government</font>s</font>, for our customers in <font color="blue">every year</font></td>
    </tr>
    <tr>
      <td>Future <font color="blue">periodic <font color="blue">financings</font></font>     arranged on behalf of our <font color="blue">customers cannot</font> be assured</td>
    </tr>
    <tr>
      <td>The absence of these     <font color="blue"><font color="blue">financings</font> could</font> result in <font color="blue">lower sales</font></td>
    </tr>
    <tr>
      <td>During fiscal 2006, we recognized dlra3cmam923cmam000 in sales related to third     <font color="blue">party <font color="blue">financings</font> pursuant</font> to a <font color="blue">German KfW Development Bank </font><font color="blue">loan program</font>     which <font color="blue">constitute</font>d 7prca of our <font color="blue">product sales</font> for the year</td>
    </tr>
    <tr>
      <td>No <font color="blue">third party sales</font>     were  obtained  during fiscal 2004 or fiscal 2005</td>
    </tr>
    <tr>
      <td>Periodic <font color="blue">financings</font>     obtained  for  customers  have had a positive <font color="blue">impact on</font> our results of     <font color="blue">operations</font> during the periods in which they are consummated, including the     <font color="blue">twelve months</font> ended <font color="blue">December </font>31, 2001 and 2002, and may not be <font color="blue">indicative</font> of     future results</td>
    </tr>
    <tr>
      <td>The <font color="blue">arrangements</font> for these <font color="blue">financings</font> and <font color="blue">resultant sales</font>     had been planned and <font color="blue">implemented over</font> a long period of time prior to our     <font color="blue">recognition</font> of the revenue for them</td>
    </tr>
    <tr>
      <td>As a result of the <font color="blue">financings</font>, we     recognized <font color="blue">relatively</font> substantial sales during <font color="blue">relatively</font> short periods</td>
    </tr>
    <tr>
      <td>Accordingly, our results of <font color="blue">operations</font> for the <font color="blue">respective fiscal quarters</font>     <font color="blue">during which</font> the sales were reflected were <font color="blue">significant</font>ly and positively     <font color="blue">impacted by</font> the timing of the <font color="blue">payments from</font> the financing and were not     <font color="blue">necessarily</font> <font color="blue">indicative</font> of our results of <font color="blue">operations</font> for any other quarter or     <font color="blue">fiscal year</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that KfW Development Bank or US     Export-Import Bank <font color="blue">financing commitments will</font> be obtained by us for our     customers in the future</td>
    </tr>
    <tr>
      <td>The absence of these <font color="blue">financings</font> would have an     adverse <font color="blue">impact on</font> our <font color="blue">sales volume</font></td>
    </tr>
    <tr>
      <td>In  late  2001, the <font color="blue">Chinese Ministry </font>of Finance notified the US     Export-Import Bank that a new framework <font color="blue">agreement</font> would be needed for future     <font color="blue">financings</font> of the type that we had provided to our customers since 1995</td>
    </tr>
    <tr>
      <td>On     January 24, 2005, the US Export-Import Bank and the <font color="blue">Chinese Ministry </font>of     Finance signed a new framework <font color="blue">agreement</font> setting forth the <font color="blue">terms under which</font>     <font color="blue">government</font>-supported  <font color="blue">financings</font>  will  be  <font color="blue">provided from</font> the US and     implemented in China</td>
    </tr>
    <tr>
      <td>In January, 2006, the implementing <font color="blue">regulations</font> for     such <font color="blue">financings</font> were issued by <font color="blue">the Chinese </font><font color="blue">government</font> and the process of     <font color="blue">finalizing</font> the specific sub-<font color="blue">agreement</font>s between the US Export-Import Bank     and the <font color="blue">commercial banks selected by</font> <font color="blue">the Chinese </font><font color="blue">government</font> was begun</td>
    </tr>
    <tr>
      <td>When it is, we anticipate that     financing <font color="blue"><font color="blue">arrangements</font> with</font> the Bank <font color="blue">will resume</font></td>
    </tr>
    <tr>
      <td>We have announced our     intention to obtain <font color="blue">such financing</font></td>
    </tr>
    <tr>
      <td>However, there can be <font color="blue">no assurances</font> that     any such sub-<font color="blue">agreement</font>s or other requisite banking <font color="blue">arrangements</font> will be     reached or consummated</td>
    </tr>
    <tr>
      <td>We may be subject to <font color="blue">product <font color="blue">liability</font></font> claims and <font color="blue">product recalls</font>, and in     the future we may not be able to obtain <font color="blue">insurance against</font> these claims at a     <font color="blue">reasonable cost</font> or at all</td>
    </tr>
    <tr>
      <td>The nature of our business <font color="blue">exposes us</font> to potential <font color="blue">product <font color="blue">liability</font></font>     risks, which are inherent in the <font color="blue">distribution</font> of <font color="blue">medical equipment</font> and     <font color="blue">healthcare products</font></td>
    </tr>
    <tr>
      <td>We may not be able to avoid <font color="blue">product <font color="blue">liability</font></font> exposure,     <font color="blue">since third parties</font> develop and <font color="blue">manufacture</font> our equipment and products</td>
    </tr>
    <tr>
      <td>If a     <font color="blue">product <font color="blue">liability</font></font> claim is <font color="blue">successfully</font> brought <font color="blue">against us</font> or any of these     third party <font color="blue"><font color="blue">manufacture</font>rs</font>, or if a <font color="blue">significant</font> product recall occurs, then     we would experience <font color="blue">adverse <font color="blue">consequences</font></font> to our reputation, we might be     required to pay damages, our insurance, legal and other <font color="blue">expenses would</font>     increase, we might lose customers and/or suppliers and there may be other     adverse results</td>
    </tr>
    <tr>
      <td>We do not maintain <font color="blue">product <font color="blue">liability</font></font> insurance, but we do request that     we  be  named  as  an  “<font color="blue">additional</font>  insured”  on  policies held by our     <font color="blue"><font color="blue">manufacture</font>rs</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that one or more <font color="blue">liability</font> claims     will not exceed the <font color="blue">coverage limits</font> of any of <font color="blue">such policies</font></td>
    </tr>
    <tr>
      <td>We currently     represent approximately 12 <font color="blue"><font color="blue">manufacture</font>rs</font> and are named as an <font color="blue">additional</font>     insured on 10 of those <font color="blue"><font color="blue">manufacture</font>rs</font>’ <font color="blue">product <font color="blue">liability</font></font> policies</td>
    </tr>
    <tr>
      <td>Since most     products  handled  by us do not <font color="blue">involve invasive measures</font>, they do not     represent a <font color="blue">significant</font> risk from <font color="blue">product <font color="blue">liability</font></font></td>
    </tr>
    <tr>
      <td>Guidant, however, is     one of the <font color="blue"><font color="blue">manufacture</font>rs</font> with respect to which we have <font color="blue">been added as</font> an     <font color="blue">additional</font> insured, since the stents <font color="blue">manufacture</font>d by it and <font color="blue">sold by us</font> are     inserted in the body</td>
    </tr>
    <tr>
      <td>-12-       _________________________________________________________________                If we or our <font color="blue"><font color="blue">manufacture</font>rs</font> fail to <font color="blue">comply with</font> <font color="blue">regulatory</font> laws and     <font color="blue">regulations</font>, we or such <font color="blue"><font color="blue">manufacture</font>rs</font> may be subject to <font color="blue"><font color="blue">enforcement</font> actions</font>,     which  <font color="blue">could affect</font> their ability to develop, market and <font color="blue">sell products</font>     <font color="blue">successfully</font></td>
    </tr>
    <tr>
      <td>This <font color="blue">could harm</font> our reputation and lead to less <font color="blue">acceptance</font> of     <font color="blue">such products by</font> the market</td>
    </tr>
    <tr>
      <td>These <font color="blue"><font color="blue">enforcement</font> actions</font> may include:       •   <font color="blue">product seizures</font>;         •   voluntary or <font color="blue">mandatory recalls</font>;         •   voluntary or <font color="blue">mandatory patient</font> or <font color="blue">physician notification</font>; and         •   <font color="blue">restrictions on</font> or <font color="blue">prohibitions against marketing</font> the products</td>
    </tr>
    <tr>
      <td>We  face <font color="blue">competition</font> that may <font color="blue">adversely</font> impact us, which impact may be     increased as a result of China’s inclusion in the <font color="blue">World Trade Organization</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">compete with</font> other <font color="blue">independent</font> <font color="blue">distributors</font> of <font color="blue">medical products</font> in     China</td>
    </tr>
    <tr>
      <td>Given the rapid pace of <font color="blue">technological</font> <font color="blue">advancement</font>, <font color="blue">particularly</font> in     the <font color="blue">medical products</font> field, other <font color="blue">independent</font> <font color="blue">distributors</font> may introduce     products  into  our markets that compete directly with the products we     distribute</td>
    </tr>
    <tr>
      <td>In  addition  to  other <font color="blue">independent</font> <font color="blue">distributors</font>, we face     <font color="blue">significant</font>   <font color="blue">competition</font>  from  direct  <font color="blue">distribution</font>  by  established     <font color="blue"><font color="blue">manufacture</font>rs</font></td>
    </tr>
    <tr>
      <td>In the <font color="blue">medical products</font> field, for example, we <font color="blue">compete with</font>     certain major <font color="blue"><font color="blue">manufacture</font>rs</font> that maintain their own <font color="blue">direct sale</font>s forces in     China</td>
    </tr>
    <tr>
      <td>In addition, to the extent that certain <font color="blue"><font color="blue">manufacture</font>rs</font> market a wide     variety  of  products  in China to <font color="blue">different</font> market sectors (including     non-medical) under one brand name, those <font color="blue"><font color="blue">manufacture</font>rs</font> may be better able     than we are to establish brand name <font color="blue">recognition</font> across industry lines</td>
    </tr>
    <tr>
      <td>As a result of China becoming a member of the <font color="blue">World Trade Organization</font>,     or  WTO, import <font color="blue">restrictions on</font> <font color="blue">medical products</font> have <font color="blue">been reduced</font> and     tariffs have <font color="blue">been lowered</font></td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">investment</font> environment has     improved for <font color="blue">companies interested</font> in establishing manufacturing <font color="blue">operations</font>     in China</td>
    </tr>
    <tr>
      <td>All of these <font color="blue">development</font>s may lead to increased imports of foreign     <font color="blue">medical products</font> and increased domestic production of such products and     therefore lead to increased <font color="blue">competition</font> in the domestic <font color="blue">medical products</font>     markets</td>
    </tr>
    <tr>
      <td>There  can  be  no assurance that we will be able to compete     <font color="blue"><font color="blue">effective</font>ly</font> with such <font color="blue"><font color="blue">manufacture</font>rs</font> and <font color="blue">distributors</font></td>
    </tr>
    <tr>
      <td>If we are not able to hire and retain <font color="blue">qualified sales <font color="blue"><font color="blue">representative</font>s</font></font> and     service  <font color="blue">specialists</font>,  then  our  marketing  <font color="blue">competitive</font>ness,  selling     <font color="blue">capabilities</font> and related <font color="blue">growth efforts will</font> be impaired</td>
    </tr>
    <tr>
      <td>We believe that to be successful we <font color="blue">must continue</font> to hire, train and     retain highly <font color="blue">qualified sales <font color="blue"><font color="blue">representative</font>s</font></font> and service <font color="blue">specialists</font></td>
    </tr>
    <tr>
      <td>Our     sales   growth  has  depended  on  hiring  and  developing  new  sales     <font color="blue"><font color="blue">representative</font>s</font></td>
    </tr>
    <tr>
      <td>Due to the <font color="blue">relationships</font> developed between our sales     <font color="blue"><font color="blue">representative</font>s</font>  and  our  customers,  upon  the  <font color="blue">departure</font> of a sales     <font color="blue">representative</font> we face the risk of losing the <font color="blue">representative</font>’s customers,     <font color="blue">especially</font> if the <font color="blue">representative</font> were to act as a <font color="blue">representative</font> of our     <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>In  addition,  the  imaging  equipment  market and other     high-<font color="blue">technology</font> <font color="blue">medical equipment</font> markets rely on the hiring and retention     of skilled service <font color="blue">specialists</font> to maintain <font color="blue">such equipment</font></td>
    </tr>
    <tr>
      <td>There may be a     shortage  of  these  skilled  <font color="blue">specialists</font>, which may result in intense     <font color="blue">competition</font> and <font color="blue">increasing salaries</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue"><font color="blue">inability</font> on</font> our part to hire or     retain such skilled <font color="blue">specialists</font> could limit our ability to <font color="blue">expand into</font>     markets and then our marketing <font color="blue">competitive</font>ness, selling <font color="blue">capabilities</font> and     related <font color="blue">growth efforts will</font> be impaired</td>
    </tr>
    <tr>
      <td>We  must  maintain  a  <font color="blue">significant</font> <font color="blue">investment</font> in <font color="blue">merchandise</font> and parts     inventories, which are costly and, if not properly managed, would result in     an <font color="blue">inability</font> to <font color="blue">provide timely marketing</font> and delivery and could result in     financial or operating <font color="blue">imbalances</font> and <font color="blue">problems with liquidity</font> and capital     resources</td>
    </tr>
    <tr>
      <td>In order to <font color="blue">provide prompt</font> and complete service to our customers, we     maintain a <font color="blue">significant</font> <font color="blue">investment</font> in <font color="blue">merchandise</font> and <font color="blue">parts inventories</font></td>
    </tr>
    <tr>
      <td>Although we <font color="blue">closely monitor</font> our inventory exposure through a variety of     inventory  control  procedures  and  policies,  including  reviews for     obsolescence and valuation, there can be no assurance that <font color="blue">such procedures</font>     and <font color="blue">policies will continue</font> to be <font color="blue">effective</font> or that                                        -13-       _________________________________________________________________           unforeseen  product <font color="blue">development</font> or price changes will not result in an     <font color="blue">inability</font>  to  provide  <font color="blue">timely supply</font> and delivery and could result in     financial or operating <font color="blue">imbalances</font> and <font color="blue">problems with liquidity</font> and capital     resources</td>
    </tr>
    <tr>
      <td>If we do not maintain good <font color="blue">relations with</font> foreign trade corporations, our     ability to <font color="blue">import products may</font> be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>In  the  sale  of our <font color="blue">medical products</font> into China, we must make a     substantial portion of our <font color="blue">sales through foreign trade corporations</font>, or     FTCs</td>
    </tr>
    <tr>
      <td>Although <font color="blue">purchasing <font color="blue">decisions</font></font> are made by the end-users, which may be     <font color="blue">individuals</font>  or  groups  having  the  required  approvals  from  their     <font color="blue">administrative <font color="blue">organizations</font></font> and which are obligated to pay the applicable     <font color="blue">purchase prices</font>, we <font color="blue">enter into</font> a <font color="blue">formal purchase contract with only</font> the     FTCs</td>
    </tr>
    <tr>
      <td>The FTCs make <font color="blue">purchases on behalf</font> of the end-users and are legally     <font color="blue">authorized by</font> <font color="blue">the Chinese </font><font color="blue">government</font> to <font color="blue">conduct import</font> business</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue">organizations</font> are chartered and <font color="blue">regulated by</font> the <font color="blue">government</font> and are formed     to <font color="blue">facilitate foreign trade</font></td>
    </tr>
    <tr>
      <td>We market our <font color="blue">products directly</font> to end-users,     but in <font color="blue">consummating sales</font> we <font color="blue">also must interact with</font> the particular FTCs     <font color="blue">representing</font> the end-users</td>
    </tr>
    <tr>
      <td>By virtue of our <font color="blue">direct contractual relationship</font>     with the FTC, <font color="blue">rather than</font> the end-user, we are to some extent <font color="blue">dependent upon</font>     the <font color="blue">continuing existence</font> of and <font color="blue">contractual compliance by</font> the FTCs until the     <font color="blue">particular transaction</font> has been completed</td>
    </tr>
    <tr>
      <td>Our dependence on sub-<font color="blue">distributors</font> and dealers could be <font color="blue">detrimental</font> to our     <font color="blue">financial condition</font> if those sub-<font color="blue">distributors</font> or dealers do not sell our     products</td>
    </tr>
    <tr>
      <td>In our <font color="blue">Medical Products </font>division we plan to increase sales of medical     <font color="blue">instrumentation</font> and other <font color="blue">medical products</font> to <font color="blue">independent</font> sub-<font color="blue">distributors</font>     and  dealers,  who  in  turn sell to end users</td>
    </tr>
    <tr>
      <td>If the efforts of such     sub-<font color="blue">distributors</font> and dealers prove <font color="blue">unsuccessful</font>, if such sub-<font color="blue">distributors</font>     and  dealers  abandon or limit their sales of our products, or if such     sub-<font color="blue">distributors</font> and dealers encounter serious financial <font color="blue">difficulties</font>, our     results of <font color="blue">operations</font> and <font color="blue">financial condition</font> could be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>Sub-<font color="blue">distributors</font> and dealers purchase from us to fill specific orders from     their customers or to maintain <font color="blue">certain predetermined stocking levels</font></td>
    </tr>
    <tr>
      <td><font color="blue">There     </font>can be no assurance that sub-<font color="blue">distributors</font> and <font color="blue">dealers will continue</font> to     purchase our products</td>
    </tr>
    <tr>
      <td>Further, such sub-<font color="blue">distributors</font> and <font color="blue">dealers generally</font>     are  not  exclusive to us and are free to sell, and do sell, competing     products</td>
    </tr>
    <tr>
      <td>If  the  Chinese  Government <font color="blue">tightens controls on purchases</font> of medical     equipment our <font color="blue">sales could</font> be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>The <font color="blue">Chinese Government </font>has adopted a number of policies relating to     purchase of <font color="blue">medical products</font> that <font color="blue">affect how</font> we can market and sell such     products</td>
    </tr>
    <tr>
      <td>For  example, for <font color="blue">certain expensive products</font> the <font color="blue">Government     </font>requires  that  a <font color="blue">tendering process</font> be <font color="blue">utilized instead</font> of <font color="blue">direct sale</font>     <font color="blue">negotiations between suppliers</font> and customers</td>
    </tr>
    <tr>
      <td>In fiscal 2006, we experienced     an  expansion  of  the <font color="blue">tendering requirement</font> to include <font color="blue">less expensive</font>     products</td>
    </tr>
    <tr>
      <td>To the extent that <font color="blue">requirements</font> such as the tendering <font color="blue">regulations</font>     might continue to be expanded, our <font color="blue">sales could</font> be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>Risks Relating to Doing Business in China            Substantially all of our assets are located in China, and <font color="blue">substantially</font>     all of our revenue is derived from our <font color="blue">operations</font> in China</td>
    </tr>
    <tr>
      <td>Accordingly, our     business, <font color="blue">financial condition</font> and results of <font color="blue">operations</font> are subject, to a     <font color="blue">significant</font> degree, to economic, political and legal <font color="blue">development</font>s in China</td>
    </tr>
    <tr>
      <td>The <font color="blue">economic system</font> of China <font color="blue">differs from</font> the economies of most developed     countries in many respects, including <font color="blue">government</font> <font color="blue">investment</font>, the level of     <font color="blue">development</font>, control of capital <font color="blue">investment</font>, control of <font color="blue">foreign exchange</font> and     <font color="blue">allocation</font> of resources</td>
    </tr>
    <tr>
      <td>-14-       _________________________________________________________________           The <font color="blue">economic policies</font> <font color="blue">of <font color="blue">the Chinese </font></font><font color="blue">government</font> and economic growth of China     could <font color="blue">adversely</font> affect us</td>
    </tr>
    <tr>
      <td>Since the late 1970s, <font color="blue">the Chinese </font><font color="blue">government</font> has been reforming the     Chinese <font color="blue">economic system</font> from a planned economy to a market-oriented economy</td>
    </tr>
    <tr>
      <td>In <font color="blue">recent years</font>, <font color="blue">the Chinese </font><font color="blue">government</font> has <font color="blue">implemented economic reform</font>     measures emphasizing decentralization, utilization of market forces in the     <font color="blue">development</font>  of  the  Chinese economy and a <font color="blue">higher level</font> of <font color="blue">management</font>     autonomy</td>
    </tr>
    <tr>
      <td>These reforms have resulted in <font color="blue">significant</font> economic growth and     social progress, but the growth has <font color="blue">been uneven both geographically</font> and     among  various  sectors  of the economy</td>
    </tr>
    <tr>
      <td>Economic growth has also been     <font color="blue">accompanied</font>  by  periods of high inflation</td>
    </tr>
    <tr>
      <td><font color="blue">The Chinese </font><font color="blue">government</font> has     implemented various policies from time to time to restrain the rate of such     economic  growth,  control  inflation  and <font color="blue">otherwise regulate economic</font>     expansion</td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">the Chinese </font><font color="blue">government</font> has attempted to control     inflation  by controlling the prices of basic commodities</td>
    </tr>
    <tr>
      <td>Although we     believe that the economic reforms and macro<font color="blue">economic policies</font> and measures     adopted by <font color="blue">the Chinese </font><font color="blue">government</font> will continue to have a positive effect on     economic <font color="blue">development</font> in China, these policies and measures may, from time to     time,  be modified or reversed</td>
    </tr>
    <tr>
      <td>Adverse changes in economic and social     <font color="blue">conditions</font> in China, in the policies <font color="blue">of <font color="blue">the Chinese </font></font><font color="blue">government</font> or in the     laws and <font color="blue">regulations</font> in China, could have a material adverse effect on the     overall economic growth of China and on infrastructure <font color="blue">investment</font> in China</td>
    </tr>
    <tr>
      <td>These <font color="blue">development</font>s could <font color="blue">adversely</font> affect our <font color="blue">financial condition</font>, results     of <font color="blue">operations</font> and business by, for example, reducing the demand for our     products and/or services</td>
    </tr>
    <tr>
      <td><font color="blue">The Chinese </font><font color="blue">legal system</font> is <font color="blue">relatively</font> new and may not provide protections     to us or our investors</td>
    </tr>
    <tr>
      <td>The  Chinese  <font color="blue">legal system</font> is a <font color="blue">civil law system based on written</font>     statutes</td>
    </tr>
    <tr>
      <td>Unlike common law systems, it is a system in which decided legal     cases have little <font color="blue">precedential value</font></td>
    </tr>
    <tr>
      <td>In 1979, the <font color="blue">Chinese Government </font>began     to promulgate a <font color="blue">comprehensive system</font> of laws and <font color="blue">regulations</font> governing     economic  matters  in  general,  including  <font color="blue">corporate organization</font> and     governance, foreign <font color="blue">investment</font>s, commerce, taxation and trade</td>
    </tr>
    <tr>
      <td>Legislation     over the past 20 years has <font color="blue">significant</font>ly enhanced the <font color="blue">protections afforded</font>     to  various forms of foreign <font color="blue">investment</font> in China</td>
    </tr>
    <tr>
      <td>However, these laws,     <font color="blue">regulations</font>  and  legal  <font color="blue">requirements</font> are <font color="blue">relatively</font> recent, and their     <font color="blue">interpretation</font> and <font color="blue">enforcement</font> involve <font color="blue">uncertainties</font>, which may limit the     legal protections available to foreign investors</td>
    </tr>
    <tr>
      <td>The <font color="blue">Chinese Government </font>underwent substantial reforms after the meeting     of the National People’s Congress in March 2003</td>
    </tr>
    <tr>
      <td>The <font color="blue">Chinese Government </font>has     reiterated its policy of <font color="blue">furthering reforms</font> in the socialist market economy</td>
    </tr>
    <tr>
      <td>No assurance can be given that these changes will not have an adverse effect     on business <font color="blue">conditions</font> in China generally or on our business in particular</td>
    </tr>
    <tr>
      <td>The  <font color="blue">conversion</font>  of Renminbi into <font color="blue">foreign currency</font> is regulated, which     <font color="blue">regulations</font> could <font color="blue">adversely</font> affect us</td>
    </tr>
    <tr>
      <td>A  <font color="blue">significant</font> portion of our revenues and operating expenses are     <font color="blue">denominated</font> in RMB Our revenues in RMB typically are converted into USD and     transferred to the United States for payment of invoices and as subsidiary     dividends</td>
    </tr>
    <tr>
      <td>The <font color="blue">transmission</font> of <font color="blue">foreign currency</font> out of China is subject to     regulation by China’s State Administration for Foreign Exchange, or SAFE It     is possible that SAFE could impose new or increase existing <font color="blue">restrictions on</font>     <font color="blue">such currency uses</font> or otherwise impose exchange controls that <font color="blue">adversely</font>     affect our practices</td>
    </tr>
    <tr>
      <td>-15-       _________________________________________________________________                The SARS outbreak or similar outbreak, such as Avian flu, could further     <font color="blue">adversely</font> affect our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>In March 2003, several countries, including China, experienced an     outbreak of a new and highly contagious form of atypical pneumonia now     commonly known as severe acute respiratory syndrome, or SARS The severity     of the outbreak in certain municipalities, such as Beijing, and provinces,     such as Guangdong Province, <font color="blue">materially affected general commercial activity</font></td>
    </tr>
    <tr>
      <td>According to the World Health Organization, over 8cmam460 cases of SARS and     more than 790 deaths had been reported in over 30 countries</td>
    </tr>
    <tr>
      <td>Since the SARS     epidemic in China had conflicting impacts on our <font color="blue">healthcare businesses</font>, the     extent  of the adverse impact that any future SARS outbreak or similar     epidemic such as Avian flu, could have on <font color="blue">the Chinese </font>economy and on us     cannot  be predicted at this time</td>
    </tr>
    <tr>
      <td>Any further epidemic outbreak could     <font color="blue">significant</font>ly disrupt our ability to adequately staff our <font color="blue">facilities</font> and may     generally disrupt <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>In particular, a large percentage of the     expatriate <font color="blue">community</font> that uses our <font color="blue">healthcare services</font> left China during the     height of the SARS epidemic and could be expected to do so again under     similar <font color="blue">circumstances</font></td>
    </tr>
    <tr>
      <td>Although no one is able to predict the future impact     of SARS, the <font color="blue">Chinese Government </font>and <font color="blue">the Chinese </font><font color="blue">healthcare industry</font> have     <font color="blue">taken measures</font> to prepare in the event of another SARS outbreak</td>
    </tr>
    <tr>
      <td>The <font color="blue">Chinese     </font>Government has indicated that any future outbreak would be contained and not     present the same magnitude of social and <font color="blue">economic disruption as</font> experienced     in  the first outbreak</td>
    </tr>
    <tr>
      <td><font color="blue">Recently in Asia </font>and elsewhere there have been     limited cases of Avian flu (avian influenza, commonly known as bird flu) in     the  human  population</td>
    </tr>
    <tr>
      <td>While  the  risk  of sustained human-to-human     <font color="blue">transmission</font> is low, the <font color="blue">possibility</font> of new virus outbreaks and related     adverse <font color="blue">impact on</font> our ability to conduct normal business <font color="blue">operations</font> cannot     be discounted</td>
    </tr>
    <tr>
      <td>Any further such outbreak could severely restrict the level     of <font color="blue">economic activity</font> in affected areas, which could have a material adverse     effect <font color="blue">on us as previously</font> experienced</td>
    </tr>
    <tr>
      <td>The  Chinese  Government  could  change  its  policies toward, or even     nationalize, private enterprise, which <font color="blue">could harm</font> our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Over  the  past several years, the <font color="blue">Chinese Government </font>has pursued     economic reform policies, including the encouragement of <font color="blue">private economic</font>     <font color="blue">activities</font>  and  decentralization  of economic regulation</td>
    </tr>
    <tr>
      <td>The <font color="blue">Chinese     </font>Government may not continue to pursue these policies or may <font color="blue">significant</font>ly     alter them to our <font color="blue">detriment from</font> time to time without notice</td>
    </tr>
    <tr>
      <td>Changes in     policies  by  the  Chinese  Government  resulting  in changes in laws,     <font color="blue">regulations</font>,  their  <font color="blue">interpretation</font>, or the imposition of confiscatory     taxation, <font color="blue">restrictions on</font> currency <font color="blue">conversion</font> or imports and sources of     supply could materially and <font color="blue">adversely</font> affect our business and operating     results</td>
    </tr>
    <tr>
      <td>The <font color="blue">nationalization</font> or other <font color="blue">expropriation</font> of <font color="blue">private <font color="blue">enterprises</font></font>     by the <font color="blue">Chinese Government </font>could result in the <font color="blue">total loss</font> of our <font color="blue">investment</font>     in China</td>
    </tr>
    <tr>
      <td><font color="blue">The Chinese </font>tax system is subject to substantial <font color="blue">uncertainties</font> in both     <font color="blue">interpretation</font> and <font color="blue">enforcement</font> of the laws</td>
    </tr>
    <tr>
      <td>In the past, following the     Chinese Government’s program of <font color="blue">privatizing</font> many state owned <font color="blue">enterprises</font>,     the <font color="blue">Chinese Government </font>attempted to augment its <font color="blue">revenues through heightened</font>     <font color="blue">tax collection efforts</font></td>
    </tr>
    <tr>
      <td><font color="blue">Continued </font><font color="blue">efforts by</font> the <font color="blue">Chinese Government </font>to     increase tax revenues could result in other <font color="blue">decisions</font> or <font color="blue">interpretation</font>s of     the  tax  laws  by the <font color="blue">taxing authorities</font> that increase our <font color="blue">future tax</font>     <font color="blue">liabilities</font> or deny us expected refunds</td>
    </tr>
    <tr>
      <td><font color="blue">Risks Related </font>to our Corporate Structure       Control by insiders and their ownership of shares having <font color="blue">disproportionate</font>     <font color="blue">voting rights could</font> have a <font color="blue">depressive</font> effect on the price of <font color="blue">common stock</font>,     impede a change in control and impede <font color="blue">management</font> replacement</td>
    </tr>
    <tr>
      <td>Certain of our present <font color="blue">management</font> <font color="blue">stockholders</font> own 775cmam000 shares of     our Class B <font color="blue">common stock</font>, which vote as a single class with the <font color="blue">common stock</font>     on all <font color="blue">matters except as otherwise</font> required by law</td>
    </tr>
    <tr>
      <td><font color="blue">The Class B </font><font color="blue">common stock</font>     and the <font color="blue">common stock</font> are <font color="blue">identical on</font> a share-for-share basis, except that     the holders of Class B <font color="blue">common stock</font> have <font color="blue">six votes per</font> share on each matter     considered by our <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td><font color="blue">As of March </font>31, 2006, the three <font color="blue">management</font>     holders of our outstanding Class B <font color="blue">common stock</font> represented approximately     12prca of our <font color="blue">outstanding capital stock</font> and were deemed to beneficially own     capital stock <font color="blue">representing</font> approximately 44prca of total voting power and may     be able to cause the                                        -16-       _________________________________________________________________           election  of  all of our <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">management</font> <font color="blue">stockholders</font> have     sufficient  voting  power to determine, in general, the outcome of any     corporate transaction or other matter submitted to our <font color="blue">stockholders</font> for     approval,  including  mergers,  consolidations  and the sale of all or     <font color="blue">substantially</font> all of our assets</td>
    </tr>
    <tr>
      <td>The <font color="blue">disproportionate</font> vote afforded the     Class B <font color="blue">common stock</font> could serve to impede or prevent a change of control</td>
    </tr>
    <tr>
      <td>As a result, potential acquirers will be discouraged from seeking to acquire     control through the purchase of <font color="blue">common stock</font>, which could have a <font color="blue">depressive</font>     effect on the price of our securities</td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">effective</font> control by     these  <font color="blue">management</font>  <font color="blue">stockholders</font> could have the effect of preventing or     frustrating attempts to influence, replace or remove <font color="blue">management</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">unissued preferred stock could</font> be issued to impede a change in control</td>
    </tr>
    <tr>
      <td>Our <font color="blue">certificate</font> of <font color="blue">incorporation authorizes</font> the issuance of 500cmam000     shares of “blank check” preferred stock with such designations, rights and     <font color="blue">preferences</font>  as  may  be  determined from time to time by our board of     <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>Accordingly,  the board of <font color="blue">directors</font> is empowered, without     stockholder  approval (but subject to applicable <font color="blue">government</font> <font color="blue">regulatory</font>     restrictions),  to  issue  preferred stock with dividend, liquidation,     <font color="blue">conversion</font>, voting or other rights that could <font color="blue">adversely</font> affect the voting     power or other rights of the holders of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In the event of     issuance,  the  preferred  stock  could  be  utilized,  under  certain     <font color="blue">circumstances</font>, as a method of <font color="blue">discouraging</font>, delaying or preventing a change     in control</td>
    </tr>
    <tr>
      <td>Although we have <font color="blue">no present intention</font> to issue any shares of our     preferred stock, there can be no assurance that we will not do so in the     future</td>
    </tr>
  </tbody>
</table>